[Pharmacology of HB 419, a new strongly effective oral antidiabetic].
D000315:Adrenalectomy; D000818:Animals; D001786:Blood Glucose / Q000032:analysis*; D002271:Carbutamide / Q000008:administration & dosage; D002747:Chlorpropamide / Q000008:administration & dosage; D003864:Depression, Chemical; D003921:Diabetes Mellitus, Experimental / Q000097:blood; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D008297:Male; D051379:Mice; D010180:Pancreatectomy; D011817:Rabbits; D051381:Rats; D013997:Time Factors; D014044:Tolbutamide / Q000008:administration & dosage / Q000494:pharmacology; D014508:Urea / Q000008:administration & dosage / Q000494:pharmacology*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D014508:Urea; D014044:Tolbutamide; D002271:Carbutamide; D002747:Chlorpropamide
Zur Pharmakologie von HB 419, einem neuen, stark wirksamen oralen Antidiabeticum.